Wei Chen
Showed that IGF2BP3-mediated m6A modification of OLR1 mRNA helps colorectal cancer evade CD8+ T cells through the PI3K/AKT/mTOR pathway
Hebei PetroChina Central Hospital · General surgery
The PubMed record lists Wei Chen as the sole author, affiliated with the Department of General Surgery at Hebei PetroChina Central Hospital, reporting that IGF2BP3-mediated m6A modification of OLR1 mRNA promotes immune evasion in colorectal cancer via the PI3K/AKT/mTOR pathway.
Milestones in the Atlas
| Year | Evidence | Study |
|---|---|---|
| 2026 | M | IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway CHEN2026B Sole author of the study linking IGF2BP3/m6A-modified OLR1 mRNA to PI3K/AKT/mTOR-driven immune evasion in colorectal cancer. |